Recommendations published April 1, 2022
The Advisory Committee on Immunization Practices (ACIP) updated its guidelines to recommend HBV vaccination for all adults less than 60 years of age, in addition to prior recommendations to vaccinate adults of any age who are at high risk for acquiring HBV. This recommendation adjustment is due to two pivotal reasons:
- Recent data has shown an overall increase in the incidence of acute HBV infection among adults in their 40s.
- Many people may not recognize they are at risk for HBV infection.